| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 01/23/2008 | EP1196404B1 Piperazine derivatives as modulators of chemokine receptor activity |
| 01/23/2008 | EP1135498B1 Antibody variants with higher binding affinity compared to parent antibodies |
| 01/23/2008 | EP0962226B1 External preparations containing watercress extract |
| 01/23/2008 | CN201008658Y Flexible medicament sustained release oral cavity film |
| 01/23/2008 | CN101111490A 4- (1h-indol-3-yl) -pyrimidin-2-ylamine derivates and their use in therapy |
| 01/23/2008 | CN101111470A Crystalline acat (acyl-coa:cholesterol o-acyltransferase) inhibitor |
| 01/23/2008 | CN101111244A Composition for promoting production of hyaluronic acid containing kaempferol and quercetin |
| 01/23/2008 | CN101111243A Classes of compounds that interact with integrins |
| 01/23/2008 | CN101111238A Cyanoacrylate monomer formulation containing diiodomethyl-p-tolylsulfone and 2,4,4'-trichloro-2' -hydroxydiphenyl ether |
| 01/23/2008 | CN101108252A Pharmaceutical composition of cyclodextrin dragon's blood and method of preparing the same |
| 01/23/2008 | CN101108240A Multipurpose pure traditional Chinese medicine externally used liquid for skin |
| 01/23/2008 | CN101108238A Burned muscle reproducing oil and method of preparing the same |
| 01/23/2008 | CN101108235A Medicament treating acne, comedo and method of preparing the same |
| 01/23/2008 | CN101108231A Medicine composition for treating psoriasis |
| 01/23/2008 | CN101108223A Burns treating ointment with functions of removing necrosis and promoting granulation |
| 01/23/2008 | CN101108209A Traditional Chinese medicine for treating beriberi |
| 01/23/2008 | CN101108181A Method of extracting flavone substance and ellagic acid from pomegranate blossom |
| 01/23/2008 | CN101108171A Budesonide intestines sustained release dextromethorphan pellets and method of manufacturing the same |
| 01/23/2008 | CN101108162A Pharmaceutical composition treating ringworm of the nails, extremity tinea and method of manufacturing the same |
| 01/23/2008 | CN100363365C Immunomodulating heterocyclic compounds |
| 01/23/2008 | CN100363044C Medicine for treating acne and its preparation method |
| 01/23/2008 | CN100363026C Medicine mixture with face-beautifying and health-care function and its preparation method |
| 01/23/2008 | CN100363016C Compound Chinese medicine prepn for fast healing trauma and its preparing method |
| 01/23/2008 | CN100362990C Fibrauretine-amino acid fluid for transfusion and its production process |
| 01/22/2008 | US7320999 Immunosuppressants, organ transplantation, autoimmune diseases, rheumatic diseases |
| 01/22/2008 | US7320994 {2-[1-(3,5-bis-trifluoromethyl-benzyl)-5-pyridin-4-yl-1H-[1,2,3]triazol-4-yl]-pyridin-3-yl}-(2-chloro-phenyl)-methanone; anxiety, depression, psychosis, and schizophrenia and other psychotic disorders; neurodegenerative disorders, multiple sclerosis and amyotrophic lateral sclerosis |
| 01/22/2008 | US7320982 Use of 4-substituted tetrahydropyridines for the manufacture of medicaments acting upon TGF-β 1 |
| 01/22/2008 | US7320964 Modulation of expression of STAT-1 dependent genes |
| 01/22/2008 | US7320792 Preventives or remedies for psoriasis containing as the active ingredient IL-6 antagonist |
| 01/22/2008 | CA2392168C Vitamin d analogues |
| 01/22/2008 | CA2333322C Nitric oxide synthase inhibitors |
| 01/22/2008 | CA2195419C Immunological activity of rhamnolipids |
| 01/22/2008 | CA2178458C Stable complexes of crosslinked polyvinylpyrrolidone and iodine and method of making the same |
| 01/17/2008 | WO2008008770A2 6, 9-disubstituted purine derivatives and their use for treating skin |
| 01/17/2008 | WO2008008544A2 Equine whole food supplements |
| 01/17/2008 | WO2008008359A2 Benzofuro-and benzothienopyryimidine modulators of the histamine h4 receptor |
| 01/17/2008 | WO2008007728A1 Oral preparation in the form enclosed in lipid membrane structure, and fatigue-ameliorating agent comprising coenzyme a as active ingredient |
| 01/17/2008 | WO2008007691A1 Salt of morpholine compound |
| 01/17/2008 | WO2008006888A1 Combination of adapalene and benzoyl peroxide for treating acne lesions |
| 01/17/2008 | WO2008006848A1 Composition comprising a retinoid and benzoyl peroxide |
| 01/17/2008 | WO2008006824A1 Novel tyrosinase inhibitors, their process of preparation and their use in human medicine and in cosmetics |
| 01/17/2008 | WO2008006581A2 Compositions and use thereof for the treatment, co-treatment or prevention of imflammatory disorders |
| 01/17/2008 | WO2008006561A1 Substituted isoxalines, pharmaceutical compositions containing same, methods of preparing same, and uses of same |
| 01/17/2008 | WO2008006287A1 Inreversible protein tyrosine kinases inhibitors and the preparation methods and uses thereof |
| 01/17/2008 | WO2008006284A1 Use of calcium salt of polyenoic acid in medical and cosmetic field |
| 01/17/2008 | WO2008006168A1 Treatment of excessive neovascularization |
| 01/17/2008 | WO2007093747A3 Use of tesaglitizar for preparing a pharmaceutical composition for treating skin disorders |
| 01/17/2008 | WO2007048645A3 Protection of oxidizable agents |
| 01/17/2008 | US20080015247 quercetin, vitamin B3, and vitamin C as only ingredients, specified weight ratio; dietary supplement or a pharmaceutical formulation; free radical induced diseases |
| 01/17/2008 | US20080015209 Compounds for the treatment of metabolic disorders |
| 01/17/2008 | US20080015200 Benzofuro- and benzothienopyrimidine modulators of the histamine H4 receptor |
| 01/17/2008 | US20080015185 N-heterocyclic inhibitors of tnf-alpha expression |
| 01/17/2008 | US20080015183 Substituted quinazolin-4-ylamine analogues |
| 01/17/2008 | US20080015174 Metabolic Disease Treatments |
| 01/17/2008 | US20080015172 Caspase inhibitors and uses thereof |
| 01/17/2008 | US20080015169 Amino-methyl substituted tetracycline compounds |
| 01/17/2008 | US20080015155 Compositions and Methods for the Treatment of Inflammatory Conditions of the Mucosae, Skin and the Eye |
| 01/17/2008 | US20080015150 Peptides and Derivatives Thereof Showing Cell Attachment, Spreading and Detachment Activity |
| 01/17/2008 | US20080014286 Metal-containing materials |
| 01/17/2008 | US20080014278 Metal-containing formulations and methods of use |
| 01/17/2008 | US20080014273 Equine whole food supplements |
| 01/17/2008 | US20080014250 Bifunctionalized polysaccharides |
| 01/17/2008 | US20080014249 Compositions and therapeutic methods involving isoflavones and analogues thereof |
| 01/17/2008 | US20080014231 Treatment articles capable of delivering intensive care and overall treatment simultaneously |
| 01/17/2008 | US20080014230 Cosmetic compositions combining a C-glycoside derivative and an N-acylamino amide derivative |
| 01/17/2008 | US20080014227 Heterocyclic compounds based on n6-substituted adenine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds |
| 01/17/2008 | US20080014197 Neutralizing human anti-igfr antibody |
| 01/17/2008 | US20080014169 Compositions for Topical Enzymatic Debridement |
| 01/17/2008 | US20080014162 Method to treat skin in need of a calmative using at least one C-Glycoside derivative |
| 01/17/2008 | US20080014159 Therapy for melanin related afflictions |
| 01/17/2008 | US20080014153 Topical Preparation For Application To The Skin Containing Natural Oil Of The Evening Primrose (Oenothera Biennis) (=Oleum Oenotherae) And Osmolytes Originating From Extremophilic Microorganisms |
| 01/17/2008 | DE4215677B4 Pharmazeutisches Mittel The pharmaceutical agent |
| 01/17/2008 | DE102007026156A1 Kosmetische Zusammensetzung mit einem Limnocitrus Littoralis-Extrakt Cosmetic composition comprising an extract Limnocitrus Littoralis |
| 01/17/2008 | DE102006032887A1 Use of a preparation comprising calcium hydroxide, an oil from plant-, animal- or mineral origin or a synthetic oil obtained from such oils, to care skin wound and to promote skin re-formation or regeneration |
| 01/17/2008 | DE102006032414A1 Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an Folsäure, Füllstoffen und Verdickern Cosmetic or dermatological preparations containing folic acid, fillers and thickeners |
| 01/17/2008 | DE102006032413A1 Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an Folsäure und einem oder mehreren Polyolen Cosmetic or dermatological preparations containing folic acid and one or more polyols |
| 01/17/2008 | DE102006032412A1 Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an Folsäure, flüchtigen und nichtflüchtigen Siliconen Cosmetic or dermatological preparations containing folic acid, volatile and non-volatile silicones |
| 01/17/2008 | DE102006032015A1 Zubereitungen zur Sebumreduktion mit einem Gehalt an Hydroxycitrat als wirksames Prinzip Preparations containing sebum reduction Hydroxycitrate as the active principle |
| 01/17/2008 | DE102006021198B4 Dermale Anwendung konzentrierter wässriger Lösungen aus Natriumchlorid oder anderen nicht giftigen anorganischen oder organischen Natriumsalzen als Mittel gegen die Hautkrankheit Vitiligo Dermal administration concentrated aqueous solutions of sodium chloride or other inorganic or organic non-toxic sodium salts as a means against the skin disease vitiligo |
| 01/17/2008 | CA2659590A1 Irreversible protein tyrosine kinases inhibitors and the preparation methods and uses thereof |
| 01/17/2008 | CA2657336A1 Substituted isoxalines, pharmaceutical compositions containing same, methods of preparing same, and uses of same |
| 01/17/2008 | CA2657308A1 Treatment of excessive neovascularization |
| 01/17/2008 | CA2656579A1 Novel tyrosinase inhibitors, their process of preparation and their use in human medicine and in cosmetics |
| 01/17/2008 | CA2656456A1 Combination of adapalene and benzoyl peroxide for treating acne lesions |
| 01/17/2008 | CA2656451A1 Composition comprising a retinoid and benzoyl peroxide |
| 01/16/2008 | EP1878754A1 Preparation and application of heparin silver |
| 01/16/2008 | EP1878748A2 Identification of unique binding interactions between certain antibodies and the human B7.1 and B7.2 costimulatory antigens |
| 01/16/2008 | EP1878738A1 Allergy-suppressive composition, allergy-suppressive food and allergy-suppressive agent |
| 01/16/2008 | EP1878730A1 Substituted isoxazolines, pharmaceutical compositions containing the same, methods of preparing the same, and uses of the same |
| 01/16/2008 | EP1878727A1 2-aminoquinazoline derivatives |
| 01/16/2008 | EP1878433A1 Topical composition comprising magmatites |
| 01/16/2008 | EP1878421A1 External preparation for skin |
| 01/16/2008 | EP1877095A1 The use of free radical scavengers for protecting and treating skin and hair damages caused by chemotherapy |
| 01/16/2008 | EP1877076A1 Use of neuropeptide y (npy) and agonists and antagonists thereof for tissue regeneration |
| 01/16/2008 | EP1635853A4 Topical composition for the treatment of skin disorders and methods of using the same |
| 01/16/2008 | EP1501809B1 Triazole derivatives as tachykinin receptor antagonists |
| 01/16/2008 | EP1469823B1 Cosmetic or dermatological use of vitamin a or esters thereof in combination with a partially methylated beta-cyclodextrin |
| 01/16/2008 | EP1399188B1 Perylenequinones for use as sonosensitizers |
| 01/16/2008 | EP1392306B1 Substituted tetrahydroisoquinolines for use in the treatment of inflammatory diseases |
| 01/16/2008 | EP1282412B1 Treating irritable bowel syndrome or disease |